CD8A and neoplasm: These pDCs can be discriminated by their distinct immunostimulatory phenotype, cytolytic function, and ability to synergize with cDCs to generate powerful tumor antigen-specific CD8+ T cell responses [112], thereby revealing another important facet of the involvement of pDCs in the TME.